Search results - ORA - Oxford University Research Archive

1 - 19 of 19

1

Journal article

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Liu, C, Ginn, HM, Dejnirattisai, W, et al.
2021-06-16

2

Journal article

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Townsend, A, Rijal, P, Xiao, J, et al.
2021-03-29

3

Journal article

Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels

Harvala, H, Robb, ML, Watkins, N, et al.
2020-12-17

4

Journal article

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

Dejnirattisai, W, Shaw, RH, Supasa, P, et al.
2021-12-20

5

Journal article

Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus

Renner, M, Flanagan, A, Dejnirattisai, W, et al.
2018-10-15

6

Journal article

Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection

Fernandez, E, Dejnirattisai, W, Cao, B, et al.
2017-09-25

7

Journal article

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Dejnirattisai, W, Huo, J, Zhou, D, et al.
2022-01-03

8

Journal article

Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

Costa Clemens, SA, Weckx, L, Clemens, R, et al.
2022-01-21

9

Journal article

Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine

Watanabe, Y, Mendonça, L, Allen, ER, et al.
2021-04-02

10

Journal article

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Zhou, D, Dejnirattisai, W, Supasa, P, et al.
2021-02-23

11

Journal article

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Supasa, P, Zhou, D, Dejnirattisai, W, et al.
2021-02-18

12

Journal article

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

Zhou, D, Duyvesteyn, HME, Chen, C-P, et al.
2020-07-31

13

Journal article

Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020

Thompson, CP, Grayson, N, Paton, R, et al.
2020-10-22

14

Journal article

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Payne, RP, Longet, S, Austin, JA, et al.
2021-10-16

15

Journal article

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

Nutalai, R, Zhou, D, Tuekprakhon, A, et al.
2022-05-20

16

Journal article

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum

Tuekprakhon, A, Nutalai, R, Dijokaite-Guraliuc, A, et al.
2022-06-09

17

Journal article

Antibody evasion by the P.1 strain of SARS-CoV-2

Dejnirattisai, W, Zhou, D, Supasa, P, et al.
2021-03-30

18

Journal article

Longitudinal analysis of antibody cross-neutralization following Zika and dengue virus infection in Asia and the Americas

Montoya, M, Collins, M, Dejnirattisai, W, et al.
2018-04-02

19

Journal article

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: three month analyses of the COV-BOOST trial

Liu, X, Munro, APS, Feng, S, et al.
2022-04-08

TO TOP